David E. I. Pyott
Independent DirectorDr. David E. I. Pyott, MA, MBA, is Strategic Advisor to the Board and Chief Executive Officer at Sienna Biopharmaceuticals, Inc. He had been a Director of Pliant Therapeutics, Inc. since January 12, 2021 until June 11, 2026. Dr. Pyott is Independent Director of Tarsus Pharmaceuticals, Inc. from February 18, 2026. He was an Advisor at Sienna Biopharmaceuticals, Inc. since July 03, 2017. Dr. Pyott serves as a Member of the Advisory Council at SVB Securities LLC. Dr. Pyott served as a Strategic Advisory Board Member of Longwood Founders Management, LLC from August 2018 until June 2019. He has been the Chairman of the Board at Bioniz, LLC since August 1, 2016. He serves as the Chairman at the California Healthcare Institute. He has been the Chairman of Bioniz Therapeutics, Inc. since June 2016. He serves as the President of the Pan-American Ophthalmological Foundation. He serves as President of the International Council of Ophthalmology Foundation. Dr. Pyott serves as Vice Chairman of the Chief Executive Roundtable for UCI. He serves as Vice Chairman of the Board of Trustees of Chapman University and is a member of the Advisory Board of the Foundation of the American Academy of Ophthalmology. He serves as a Member of the Directors' Board of the University of California (Irvine) Graduate School of Management. He is a Governor of London Business School. He is also involved on the Boards of many other US and international eyecare charities. He has been a Director of MAP Pharmaceuticals, Inc. since March 1, 2013. He has been an Independent Director of Alnylam Pharmaceuticals, Inc. since December 18, 2015. Dr. Pyott serves as a Director of the Pharmaceutical Research and Manufacturers of America. He was a Director of Rani Therapeutics Holdings, Inc. since October 2016. He has been a Director of Bioniz, LLC since June 2015. He had been an Independent Director of BioMarin Pharmaceutical Inc. since January 4, 2016 until May 2025. Dr. Pyott joined BioMarin Pharmaceutical Inc. on January 04, 2016. He served as an Independent Director of Avery Dennison Corporation from November 1999 until April 23, 2020 and served as its Lead Independent Director from April 22, 2010 until April 23, 2020. He has been a Director of Bioniz Therapeutics, Inc. He had been a Member of the Supervisory Board at Koninklijke Philips N.V. since May 7, 2015 until May 08, 2025. He served as a Director of Pacific LifeCorp, Large of Biotechnology Industry Organization and EyeCare America. He serves as Director At Large of the Biotechnology Innovation Organization. He serves as a member of the Supervisory Board of Royal Philips in the Netherlands. He served as the Chief Executive Officer of Allergan, Inc. from January 1998 to March 2015. He served as the President of Allergan, Inc. from January 1998 to February 1, 2006 and also from March 27, 2011 to June 2013. He served as the Chief Administrative Officer of Allergan, Inc. since August 1, 2010. He served as the Head of the Nutrition Division of Novartis AG from 1995 to December 1997. He served as the President and Chief Executive Officer of Sandoz Nutrition Corp. from 1992 to 1995 and served as its General Manager of Sandoz Nutrition from 1990 to 1992. He worked in various positions within the Sandoz Nutrition group since 1980. He served as the Chairman of Allergan, Inc. from March 2001 until March 2015. He served as a Director of Allergan, Inc. since January 1998. He served as a Director of Abbott Medical Optics Inc. from October 2001 to June 29, 2003. He served as an Independent Director of Edwards Lifesciences Corporation from 2000 to October 3, 2014. He served as a Director of Pacific Mutual Holding Company. Dr. Pyott was recognized by Harvard Business Review as one of "The 100 Best Performing CEOs in the World" in 2014. In 2006, Dr. Pyott was bestowed with the honor of Commander of the Most Excellent Order of the British Empire (CBE) by Majesty the Queen. He is also an active philanthropist and created the David E.I. Pyott Foundation to educate physicians on improving patient outcomes. Dr. Pyott holds a Diploma in International and European Law from the Europa Institute at the University of Amsterdam, a Master of Arts degree and an Honorary Degree in Medicine from the University of Edinburgh and a Master of Business Administration degree from the London Business School.
Positions
- Company NameAlnylam Pharmaceuticals, Inc.Stock CodeALNYPositionIndependent DirectorColleagues
- YLYvonne L. GreenstreetCEO & Director
- AWAmy W. SchulmanIndependent Chair of the Board
- PAPhillip A. SharpCo-Founder, Member of the Scientific Advisory Board
- JVJeffrey V. PoultonCFO & Executive VP
- BABryan Andrew SupranChief Legal Officer
- PPPushkal P. GargExecutive VP & Chief Research & Development Officer
- MMMuthiah ManoharanSenior VP of Innovation Chemistry & Distinguished Scientist and Member of Scientific Advisory Board
